v3.26.1
FINANCIAL INSTRUMENTS - Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash Equivalents (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]        
Cash and cash equivalents $ 2,222,435 $ 1,311,679 [1]    
Restricted cash equivalents 850,000 0 [1]    
Cash, cash equivalents and restricted cash equivalents $ 3,072,435 $ 1,311,679 $ 1,048,803 $ 942,842
[1]
(1)December 31, 2025 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026.